CareMax — Q3 2021 Earnings Presentation
16 slides from CareMax's earnings presentation, Nov 15, 2021
Slide 1: Third Quarter 2021 Earnings Presentation
Third Quarter 2021 Earnings Presentation November 15, 2021 EX-99.2
Slide 2: Disclaimer
Disclaimer Presentation This presentation (“Presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (“CareMax” or the “Company”) or
Slide 3: CareMax at a Glance
CareMax at a Glance 26K+ Medicare Advantage Members 2011 Year Founded 42 Medical Centers 95+ Employed Providers 68K+ Total Members We are… A founder-led, technology-enabled, whole person healthcare platform providing value-based care and chronic disease management to seniors. Our mission… Is to empo
Slide 4: Third Quarter 2021 Update
Third Quarter 2021 Update Medical Expense Ratio reflects external provider costs divided by Medicare and Medicaid risk-based revenues. Strategic Highlights Closed the acquisition of DNF Medical Centers on September 1, 2021, adding approximately 4,000 Medicare lives and expanding CareMax’s footprint
Slide 5: Our Medical Center Footprint and Medicare Advantage Membership Have Scaled Quickly
Our Medical Center Footprint and Medicare Advantage Membership Have Scaled Quickly Includes potential additional centers and membership from acquisitions in our pipeline. Medical Centers Medicare Advantage Members 1 1 ~7.5x ~10x
Slide 6: We Have a Track Record of Meaningfully Improving the Health Outcomes and Costs
We Have a Track Record of Meaningfully Improving the Health Outcomes and Costs of the Highest Acuity Patients Figure reflects legacy CareMax as of year-end 2020. Reflects CareMax patients enrolled in HealthSun health plans for 2019 dates of service. External Provider Cost PMPM by Member Tenure2 (14)
Slide 7: We Are Well Positioned to Execute Our De Novo Strategy in 22
We Are Well Positioned to Execute Our De Novo Strategy in 2022 We have conducted a rigorous prioritization of sites in our pipeline based on detailed diligence and forecasted return on capital We have onboarded two Market Presidents to oversee pre-opening expansion efforts in priority states We have
Slide 8: De Novo Centers Offer Compelling Returns on Investment and Require Limited Upfront Capital
De Novo Centers Offer Compelling Returns on Investment and Require Limited Upfront Capital Includes initial buildout costs and operating losses up to platform contribution breakeven. Initial CareMax operating losses include self-financed FF&E and incremental costs associated with payor partner and t
Slide 9: Excluding the Impact of COVID, Our Underlying Business Has Continued to Scale Profitably
Excluding the Impact of COVID, Our Underlying Business Has Continued to Scale Profitably Note: Figures give effect to the combinations of CareMax, IMC, and Care Holdings as if they had occurred in historical periods. Platform contribution defined as revenue less external provider costs and cost of c
Slide 10: We Have Successfully Managed COVID Utilization Among Our Patients Despite the Delta Surge
We Have Successfully Managed COVID Utilization Among Our Patients Despite the Delta Surge in Florida CareMax and IMC Medicare only. COVID Admissions More Benign Than Expected1 In-Person PCP Visits Have Fully Recovered1 3Q21 COVID hospitalizations among our Medicare members peaked at a lower level th
Slide 11: Third Quarter 2021 Financial Supplement
Third Quarter 2021 Financial Supplement
Slide 12: Reconciliation to Non-GAAP Revenue and Platform Contribution
Reconciliation to Non-GAAP Revenue and Platform Contribution Reflects impact of business combination of CareMax, IMC, and Care Holdings and other pro forma adjustments as may arise from the combination. 3Q20 Non-GAAP Reconciliation 3Q21 Non-GAAP Reconciliation 1 1
Slide 13: Historical Non-GAAP Financial Summary
Historical Non-GAAP Financial Summary Note: Figures give effect to the combinations of CareMax, IMC, and Care Holdings as if they had occurred in historical periods. Totals may not sum due to rounding. Includes pre-opening costs and operating losses incurred by de novo centers up to 12 months after
Slide 14: Reconciliation to Adjusted EBITDA
Reconciliation to Adjusted EBITDA Note: Pro forma and non-GAAP figures give effect to the combinations of CareMax, IMC, and Care Holdings as if they had occurred in historical periods. Totals may not sum due to rounding. Pro forma net income replaces historical interest expense and D&A with go-forwa
Slide 15: Capitalization and Liquidity
Capitalization and Liquidity Excludes unvested warrants. Warrants have a strike price of $11.50/share and (other than the Related warrants) are subject to a $18.00 redemption cap. Shares issuable through warrants assumes treasury stock method. 50% of earnout shares are issuable if the volume weighte
Slide 16: Q&A
Caremax Q&A